US Stock MarketDetailed Quotes

Vertex Pharmaceuticals (VRTX)

Watchlist
  • 441.560
  • +9.700+2.25%
Trading Apr 8 15:45 ET
112.32BMarket Cap28.82P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vertex Pharmaceuticals (VRTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
8.90%12B
9.55%3.19B
10.99%3.08B
12.06%2.96B
2.96%2.77B
11.66%11.02B
15.66%2.91B
11.61%2.77B
6.11%2.65B
13.30%2.69B
Operating revenue
8.63%11.97B
9.55%3.19B
10.99%3.08B
11.28%2.94B
2.59%2.76B
11.66%11.02B
15.66%2.91B
11.61%2.77B
6.11%2.65B
13.30%2.69B
Cost of revenue
7.89%1.65B
10.06%466M
5.65%414.8M
9.57%407.5M
5.95%363M
21.26%1.53B
15.05%423.4M
23.19%392.6M
20.51%371.9M
28.36%342.6M
Gross profit
9.07%10.35B
9.46%2.72B
11.86%2.66B
12.47%2.56B
2.52%2.41B
10.25%9.49B
15.76%2.49B
9.91%2.38B
4.08%2.27B
11.39%2.35B
Operating expense
-40.39%5.8B
-73.46%1.59B
14.03%1.42B
4.80%1.4B
21.59%1.38B
101.45%9.72B
248.95%6B
16.19%1.25B
27.71%1.34B
15.06%1.13B
Selling and administrative expenses
19.72%1.75B
28.97%487M
19.71%445.1M
14.08%424.6M
15.67%396.4M
28.83%1.46B
2.30%377.6M
40.94%371.8M
41.74%372.2M
42.14%342.7M
Research and development costs
-51.05%4.04B
-80.33%1.11B
11.62%977.7M
1.22%978.4M
24.15%979.7M
123.81%8.26B
316.30%5.63B
8.14%875.9M
23.02%966.6M
6.26%789.1M
Operating profit
2,051.33%4.55B
132.15%1.13B
9.47%1.24B
23.46%1.15B
-15.22%1.03B
-106.17%-233.4M
-919.79%-3.52B
3.72%1.13B
-17.72%934.9M
8.18%1.22B
Net non-operating interest income expense
-15.84%477.6M
-5.42%118.6M
-1.84%122.4M
-19.03%118.7M
-30.97%117.9M
-0.54%567.5M
-25.75%125.4M
-20.57%124.7M
9.81%146.6M
53.60%170.8M
Non-operating interest income
-17.92%490.9M
-4.91%121.9M
-4.92%125.7M
-21.79%122.4M
-33.28%120.9M
-2.70%598.1M
-28.58%128.2M
-21.26%132.2M
8.15%156.5M
47.80%181.2M
Non-operating interest expense
-56.54%13.3M
17.86%3.3M
-56.00%3.3M
-62.63%3.7M
-71.15%3M
-30.61%30.6M
-73.58%2.8M
-31.19%7.5M
-11.61%9.9M
-8.77%10.4M
Other net income (expense)
-354.21%-388.8M
-98.19%82.1M
-93.79%-62.4M
100.23%10.1M
-287.95%-418.6M
-397.22%-85.6M
723.43%4.53B
53.20%-32.2M
-4,029.92%-4.47B
68.62%-107.9M
Special income (charges)
-76,320.00%-381.1M
-98.34%75.6M
-243.79%-52.6M
99.93%-3.1M
-422.82%-401M
-99.03%500K
711.67%4.54B
71.08%-15.3M
-3,948.77%-4.45B
77.78%-76.7M
-Less：Restructuring and merger&acquisition
520.00%2.1M
175.00%900K
-733.33%-1.9M
80.00%900K
2,300.00%2.2M
99.03%-500K
97.61%-1.2M
-75.00%300K
183.33%500K
94.74%-100K
-Less:Impairment of capital assets
--379M
--0
--0
--0
--379M
--0
--0
--0
--0
--0
-Less:Other special charges
----
----
263.33%54.5M
-99.95%2.2M
-74.22%19.8M
778.09%4.63B
391.57%87.5M
-70.99%15M
3,926.33%4.45B
-77.87%76.8M
Other non- operating income (expenses)
91.06%-7.7M
143.62%6.5M
42.01%-9.8M
157.14%13.2M
43.59%-17.6M
-277.63%-86.1M
-52.04%-14.9M
-6.29%-16.9M
-1,543.75%-23.1M
-2,500.00%-31.2M
Income before tax
1,768.49%4.64B
17.11%1.33B
6.10%1.3B
137.83%1.28B
-42.90%730.4M
-94.33%248.5M
-0.97%1.14B
3.81%1.22B
-391.97%-3.39B
43.48%1.28B
Income tax
-12.00%690M
-37.40%139.9M
20.82%215.9M
23.57%250.1M
-53.15%84.1M
3.14%784.1M
25.00%223.5M
24.18%178.7M
-17.66%202.4M
-6.36%179.5M
Net income
838.09%3.95B
30.46%1.19B
3.59%1.08B
128.74%1.03B
-41.22%646.3M
-114.80%-535.6M
-5.76%913M
0.98%1.05B
-492.44%-3.59B
57.13%1.1B
Net income continuous Operations
838.09%3.95B
30.46%1.19B
3.59%1.08B
128.74%1.03B
-41.22%646.3M
-114.80%-535.6M
-5.76%913M
0.98%1.05B
-492.44%-3.59B
57.13%1.1B
Minority interest income
Net income attributable to the parent company
838.09%3.95B
30.46%1.19B
3.59%1.08B
128.74%1.03B
-41.22%646.3M
-114.80%-535.6M
-5.76%913M
0.98%1.05B
-492.44%-3.59B
57.13%1.1B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
838.09%3.95B
30.46%1.19B
3.59%1.08B
128.74%1.03B
-41.22%646.3M
-114.80%-535.6M
-5.76%913M
0.98%1.05B
-492.44%-3.59B
57.13%1.1B
Basic earnings per share
843.27%15.46
32.11%4.69
4.69%4.24
128.88%4.02
-40.85%2.52
-114.80%-2.08
-5.59%3.55
1.00%4.05
-492.11%-13.92
56.62%4.26
Diluted earnings per share
836.54%15.32
32.86%4.65
4.74%4.2
128.66%3.99
-40.86%2.49
-114.97%-2.08
-5.66%3.5
1.01%4.01
-495.45%-13.92
56.51%4.21
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 8.90%12B9.55%3.19B10.99%3.08B12.06%2.96B2.96%2.77B11.66%11.02B15.66%2.91B11.61%2.77B6.11%2.65B13.30%2.69B
Operating revenue 8.63%11.97B9.55%3.19B10.99%3.08B11.28%2.94B2.59%2.76B11.66%11.02B15.66%2.91B11.61%2.77B6.11%2.65B13.30%2.69B
Cost of revenue 7.89%1.65B10.06%466M5.65%414.8M9.57%407.5M5.95%363M21.26%1.53B15.05%423.4M23.19%392.6M20.51%371.9M28.36%342.6M
Gross profit 9.07%10.35B9.46%2.72B11.86%2.66B12.47%2.56B2.52%2.41B10.25%9.49B15.76%2.49B9.91%2.38B4.08%2.27B11.39%2.35B
Operating expense -40.39%5.8B-73.46%1.59B14.03%1.42B4.80%1.4B21.59%1.38B101.45%9.72B248.95%6B16.19%1.25B27.71%1.34B15.06%1.13B
Selling and administrative expenses 19.72%1.75B28.97%487M19.71%445.1M14.08%424.6M15.67%396.4M28.83%1.46B2.30%377.6M40.94%371.8M41.74%372.2M42.14%342.7M
Research and development costs -51.05%4.04B-80.33%1.11B11.62%977.7M1.22%978.4M24.15%979.7M123.81%8.26B316.30%5.63B8.14%875.9M23.02%966.6M6.26%789.1M
Operating profit 2,051.33%4.55B132.15%1.13B9.47%1.24B23.46%1.15B-15.22%1.03B-106.17%-233.4M-919.79%-3.52B3.72%1.13B-17.72%934.9M8.18%1.22B
Net non-operating interest income expense -15.84%477.6M-5.42%118.6M-1.84%122.4M-19.03%118.7M-30.97%117.9M-0.54%567.5M-25.75%125.4M-20.57%124.7M9.81%146.6M53.60%170.8M
Non-operating interest income -17.92%490.9M-4.91%121.9M-4.92%125.7M-21.79%122.4M-33.28%120.9M-2.70%598.1M-28.58%128.2M-21.26%132.2M8.15%156.5M47.80%181.2M
Non-operating interest expense -56.54%13.3M17.86%3.3M-56.00%3.3M-62.63%3.7M-71.15%3M-30.61%30.6M-73.58%2.8M-31.19%7.5M-11.61%9.9M-8.77%10.4M
Other net income (expense) -354.21%-388.8M-98.19%82.1M-93.79%-62.4M100.23%10.1M-287.95%-418.6M-397.22%-85.6M723.43%4.53B53.20%-32.2M-4,029.92%-4.47B68.62%-107.9M
Special income (charges) -76,320.00%-381.1M-98.34%75.6M-243.79%-52.6M99.93%-3.1M-422.82%-401M-99.03%500K711.67%4.54B71.08%-15.3M-3,948.77%-4.45B77.78%-76.7M
-Less：Restructuring and merger&acquisition 520.00%2.1M175.00%900K-733.33%-1.9M80.00%900K2,300.00%2.2M99.03%-500K97.61%-1.2M-75.00%300K183.33%500K94.74%-100K
-Less:Impairment of capital assets --379M--0--0--0--379M--0--0--0--0--0
-Less:Other special charges --------263.33%54.5M-99.95%2.2M-74.22%19.8M778.09%4.63B391.57%87.5M-70.99%15M3,926.33%4.45B-77.87%76.8M
Other non- operating income (expenses) 91.06%-7.7M143.62%6.5M42.01%-9.8M157.14%13.2M43.59%-17.6M-277.63%-86.1M-52.04%-14.9M-6.29%-16.9M-1,543.75%-23.1M-2,500.00%-31.2M
Income before tax 1,768.49%4.64B17.11%1.33B6.10%1.3B137.83%1.28B-42.90%730.4M-94.33%248.5M-0.97%1.14B3.81%1.22B-391.97%-3.39B43.48%1.28B
Income tax -12.00%690M-37.40%139.9M20.82%215.9M23.57%250.1M-53.15%84.1M3.14%784.1M25.00%223.5M24.18%178.7M-17.66%202.4M-6.36%179.5M
Net income 838.09%3.95B30.46%1.19B3.59%1.08B128.74%1.03B-41.22%646.3M-114.80%-535.6M-5.76%913M0.98%1.05B-492.44%-3.59B57.13%1.1B
Net income continuous Operations 838.09%3.95B30.46%1.19B3.59%1.08B128.74%1.03B-41.22%646.3M-114.80%-535.6M-5.76%913M0.98%1.05B-492.44%-3.59B57.13%1.1B
Minority interest income
Net income attributable to the parent company 838.09%3.95B30.46%1.19B3.59%1.08B128.74%1.03B-41.22%646.3M-114.80%-535.6M-5.76%913M0.98%1.05B-492.44%-3.59B57.13%1.1B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 838.09%3.95B30.46%1.19B3.59%1.08B128.74%1.03B-41.22%646.3M-114.80%-535.6M-5.76%913M0.98%1.05B-492.44%-3.59B57.13%1.1B
Basic earnings per share 843.27%15.4632.11%4.694.69%4.24128.88%4.02-40.85%2.52-114.80%-2.08-5.59%3.551.00%4.05-492.11%-13.9256.62%4.26
Diluted earnings per share 836.54%15.3232.86%4.654.74%4.2128.66%3.99-40.86%2.49-114.97%-2.08-5.66%3.51.01%4.01-495.45%-13.9256.51%4.21
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.58%
Sample Name
Sample Code
 +16.81%
Sample Name
Sample Code
 +13.50%
4
United Sts Brent Oil Fd Lp Unit
BNO
+11.03%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.28%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.94%
Sample Name
Sample Code
 +13.96%
Sample Name
Sample Code
 +13.85%
4
ASE Technology
ASX
+10.75%
5
Kingsoft Cloud
KC
+9.62%
View More
Middle East conflict spreads to the stock market! How should investors respond?
A major turning point has emerged in the US-Iran situation! Trump announced a two-week suspension of military action against Iran, and both Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -